Researching: Eli Lilly

Lilly Spends Up to $3.8B on Three Vaccine Developers

Lilly preps for ph. 2 launch after Verve gene editor cuts cholesterol on par with PCSK9 inhibitors

Lilly Targets Church-Linked Pharmacies in $200M Trulicity Rebate Fraud Allegation

CHMP Diverges from FDA, Backs AZ’s Camizestrant and Novo’s Oral Wegovy

Lilly’s triple-G drug helps patients lose roughly a quarter of weight, showcasing competitive profile

Lilly Extends Genetic Medicine Bet With $202M Engage Biologics Buy

Race intensifies to lead next wave of obesity drugs as trial results loom

Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies

Novo Nordisk’s Wegovy pill lifts Q1 and investor confidence

Lilly plans new $4.5B manufacturing investment in Indiana